Literature DB >> 17892975

Antinociceptive synergistic interaction between clonidine and ouabain on thermal nociceptive tests in the rat.

Weian Zeng1, Xiangnan Chen, Shuji Dohi.   

Abstract

UNLABELLED: The antinociceptive effect produced by spinal injection of clonidine (an alpha(2)-adrenergic agonist) is mediated by a cholinergic mechanism. We aimed in the current study to evaluate the antinociceptive interaction between intrathecally administered ouabain, an inhibitor of Na(+), K(+)-ATPase, and clonidine. We used rats chronically implanted with lumbar intrathecal catheters to examine the ability of intrathecal clonidine and ouabain and the mixtures of clonidine-ouabain to alter tail-flick latency. To characterize the interaction, isobolographic analysis was performed. Intrathecal clonidine (0.5-10 microg) and ouabain (0.1-5 microg) produced significant dose- and time-dependent antinociception in the tail-flick tests. The median effective dose (ED(50)) values for intrathecally administered ouabain and clonidine were 2.3 microg and 4.7 microg, respectively. The experimental point for the ouabain-clonidine combination decreased significantly (P < .05) below the lines of additivity. Isobolographic analysis exhibited a synergistic interaction after the coadministration of ouabain and clonidine. No motor impairment was observed in the animals after intrathecal administration of the combination of ouabain and clonidine or clonidine alone. Intrathecal pretreatment with atropine but not yohimbine blocked the antinociceptive effect of ouabain and attenuated its interaction with spinal clonidine. These results suggest that the synergistic interaction of ouabain and clonidine were probably mediated, at least in part, via an enhancement of cholinergic transmission in the spinal nociceptive processing system. PERSPECTIVE: Although intrathecal clonidine produces pronounced analgesia, antinociceptive doses of intrathecal clonidine produce several side effects, including hypotension, bradycardia, and sedation. This article presents antinociceptive synergistic interaction between clonidine and ouabain on thermal nociceptive tests in the rat.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892975     DOI: 10.1016/j.jpain.2007.07.006

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  7 in total

Review 1.  Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities.

Authors:  S K Segall; W Maixner; I Belfer; T Wiltshire; Z Seltzer; L Diatchenko
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-05       Impact factor: 4.388

2.  Anti-inflammatory and antinociceptive activity of ouabain in mice.

Authors:  Danielle Ingrid Bezerra de Vasconcelos; Jacqueline Alves Leite; Luciana Teles Carneiro; Márcia Regina Piuvezam; Maria Raquel Vitorino de Lima; Liana Clébia Lima de Morais; Vivian Mary Rumjanek; Sandra Rodrigues-Mascarenhas
Journal:  Mediators Inflamm       Date:  2011-05-26       Impact factor: 4.711

3.  Anti-inflammatory and antinociceptive activities of bufalin in rodents.

Authors:  Lili Wen; Yang Huang; Xianbiao Xie; Wan Huang; Junqiang Yin; Wenqian Lin; Qiang Jia; Weian Zeng
Journal:  Mediators Inflamm       Date:  2014-02-26       Impact factor: 4.711

4.  Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test.

Authors:  Handong Ouyang; Peizong Wang; Wan Huang; Qiang Li; Bilin Nie; Weian Zeng
Journal:  Pain Res Manag       Date:  2015-09-10       Impact factor: 3.037

Review 5.  Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.

Authors:  Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2017-11-10       Impact factor: 4.566

6.  Endogenous Na+, K+-ATPase inhibitors and CSF [Na+] contribute to migraine formation.

Authors:  Noah B Gross; Nastaren Abad; David Lichtstein; Shiri Taron; Lorena Aparicio; Alfred N Fonteh; Xianghong Arakaki; Robert P Cowan; Samuel C Grant; Michael G Harrington
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

7.  Antinociceptive effectiveness of the inhibition of NCX reverse-mode action in rodent neuropathic pain model.

Authors:  Yang Huang; Li-Li Wen; Jing-Dun Xie; Han-Dong Ouyang; Dong-Tai Chen; Wei-An Zeng
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.